文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

右美托咪定与丙泊酚:成人程序镇静中与氯胺酮的有效组合——一项随机临床试验

Dexmedetomidine versus propofol: An effective combination with ketamine for adult procedural sedation: A randomized clinical trial.
PubMed 文献 · Am J Emerg Med · 2023-08-15
一句话结论成人急诊程序镇静中,氯胺酮-右美托咪定与氯胺酮-丙泊酚均有效安全,前者氧饱和度下降更少、平均动脉压变化更小,后者恢复时间更短。

该前瞻性、随机、双盲临床试验纳入135例需程序镇静镇痛的成人急诊患者,等分为氯胺酮-右美托咪定组、氯胺酮-丙泊酚组和单用氯胺酮组,必要时追加氯胺酮补救。三组呼吸事件发生率相似,氯胺酮-右美托咪定组氧饱和度下降幅度更小(1.9% vs 6.5% vs 3.8%,P=0.015),平均动脉压较基线变化在单用氯胺酮组和氯胺酮-丙泊酚组均大于氯胺酮-右美托咪定组,单用氯胺酮组心动过速发生率显著更高,氯胺酮-丙泊酚组恢复时间较其他两组更短。作者认为氯胺酮-右美托咪定和氯胺酮-丙泊酚均为成人急诊程序镇静有效安全的组合,恢复良好且血流动力学稳定。

要点

  • 氯胺酮-右美托咪定组氧饱和度下降幅度为1.9%,低于氯胺酮-丙泊酚组的6.5%和单用氯胺酮组的3.8%(P=0.015)。
  • 平均动脉压较基线变化:单用氯胺酮组和氯胺酮-丙泊酚组分别比氯胺酮-右美托咪定组高12.9 mmHg(95%CI 9.5至20.3)和8.6 mmHg(95%CI 3.4至13.7)。
  • 单用氯胺酮组心动过速发生率显著高于其他组。
  • 恢复时间氯胺酮-丙泊酚组较单用氯胺酮组短9.8 min(95%CI 2.5至17.1),较氯胺酮-右美托咪定组短8.3 min(95%CI 1.5至15.1)。
  • 三组呼吸事件发生率相似,无患者需要气管插管。

适用人群与场景

  • 成人(≥18岁)急诊科需程序镇静镇痛的疼痛性操作患者。

处置流程与药物剂量

  • 三组分别接受氯胺酮-右美托咪定、氯胺酮-丙泊酚或单用氯胺酮进行程序镇静镇痛;镇静不足时三组均追加氯胺酮作为补救药物。
  • 从基线至程序镇静诱导后120 min记录氧饱和度、心率和血压。

研究设计与关键结果

  • 前瞻性、随机、双盲临床试验,纳入135例成人急诊程序镇静患者,等分为氯胺酮-右美托咪定组、氯胺酮-丙泊酚组和单用氯胺酮组。
  • 患者平均年龄38.16±19.09岁,三组人口学变量、疼痛评分和操作类型无差异。
  • 氧饱和度下降幅度:氯胺酮-右美托咪定组1.9%,氯胺酮-丙泊酚组6.5%,单用氯胺酮组3.8%(P=0.015)。
  • 平均动脉压较基线变化:单用氯胺酮组和氯胺酮-丙泊酚组分别比氯胺酮-右美托咪定组高12.9 mmHg(95%CI 9.5至20.3)和8.6 mmHg(95%CI 3.4至13.7)。
  • 单用氯胺酮组心动过速发生率显著更高。
  • 恢复时间:氯胺酮-丙泊酚组较单用氯胺酮组短9.8 min(95%CI 2.5至17.1),较氯胺酮-右美托咪定组短8.3 min(95%CI 1.5至15.1)。
  • 三组呼吸事件发生率相似,无患者需要气管插管。

证据类型、等级与局限

  • 证据类型:前瞻性、随机、双盲临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,氯胺酮-右美托咪定与氯胺酮-丙泊酚均为成人急诊程序镇静的有效安全组合,恢复良好且血流动力学稳定。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Recently, drug combination protocols have been preferred over single drugs in procedural sedation and analgesia (PSA). This study aimed to compare the effectiveness and hemodynamic profile of ketamine-dexmedetomidine (ketodex) and ketofol as drug combinations with ketamine as a single medication for PSA in the emergency department (ED).

METHODS: This prospective, randomized, double-blind clinical trial was performed among adult patients (≥18 years) requiring PSA for a painful procedure in the ED. 135 patients were enrolled and assigned into three equal groups to receive either ketodex, ketofol, or ketamine. Additional ketamine was used as a rescue agent for inadequate sedation in three groups. Oxygen saturation, heart rate, and blood pressure were recorded from baseline until 120 min after induction of PSA. Adverse events, hemodynamic variables, induction, and recovery time were recorded and compared between groups.

RESULTS: The mean age of the patients was 38.16 ± 19.09 years and no differences were observed between the three groups in terms of demographic variables, pain scores, and procedures between the three groups. Respiratory events had similar incidences between the three groups. The O2 reduction was less in the Ketodex group in comparison with Ketofol and Ketamine groups (1.9%, 6.5%, and 3.8%, P = 0.015). No patient needed endotracheal intubation. Changes in mean arterial pressure from the baseline in Ketamine and Ketofol groups compared to Ketodex was higher (difference was 12.9 mmHg [95% CI, 9.5 to 20.3] and 8.6 mmHg [95% CI, 3.4 to 13.7]. Tachycardia in the Ketamine group had a significantly higher incidence. The recovery time was statistically shorter in the Ketofol group in comparison with other groups. The differences between Ketofol with Ketamine and Ketodex groups were 9.8 min (95% CI, [2.5 to 17.1]) and 8.3 min (95% CI, [1.5 to 15.1]).

CONCLUSION: Ketodex, as well as ketofol, were effective and safe combinations with good recovery profiles and hemodynamic stability for adult PSA in ED.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Esmaillian M, Kouhestani S, Azizkhani R, et al. Dexmedetomidine versus propofol: An effective combination with ketamine for adult procedural sedation: A randomized clinical trial. Am J Emerg Med. 2023. PMID: 37639920. doi:10.1016/j.ajem.2023.08.025

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。